CSPC Pharmaceutical Group Ltd. Stock

Equities

1093

HK1093012172

Pharmaceuticals

Delayed Hong Kong S.E. 23:59:20 2024-06-16 EDT 5-day change 1st Jan Change
6.68 HKD -2.05% Intraday chart for CSPC Pharmaceutical Group Ltd. -3.19% -7.99%

Financials

Sales 2024 * 37.88B 4.85B 6.66B Sales 2025 * 41B 5.25B 7.2B Capitalization 80.78B 10.34B 14.2B
Net income 2024 * 7.15B 916M 1.26B Net income 2025 * 7.68B 983M 1.35B EV / Sales 2024 * 1.7 x
Net cash position 2024 * 16.23B 2.08B 2.85B Net cash position 2025 * 20.9B 2.68B 3.67B EV / Sales 2025 * 1.46 x
P/E ratio 2024 *
11.4 x
P/E ratio 2025 *
10.6 x
Employees 23,500
Yield 2024 *
3.11%
Yield 2025 *
3.23%
Free-Float 70.15%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.16%
1 week-2.85%
Current month+2.87%
1 month+1.34%
3 months+1.79%
6 months-3.26%
Current year-6.06%
More quotes
1 week
6.71
Extreme 6.71
6.94
1 month
6.29
Extreme 6.29
7.21
Current year
5.56
Extreme 5.56
7.37
1 year
5.20
Extreme 5.2
7.41
3 years
5.20
Extreme 5.2
12.10
5 years
5.20
Extreme 5.2
12.68
10 years
2.77
Extreme 2.7708
13.93
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 95-12-31
Chairman 70 97-12-31
Director/Board Member 41 20-07-31
Members of the board TitleAgeSince
Chairman 70 97-12-31
Director/Board Member 55 05-12-31
Director/Board Member 64 12-12-20
More insiders
Date Price Change Volume
24-06-16 6.68 -2.05% 12 916 475
24-06-14 6.82 -1.16% 36,683,440
24-06-13 6.9 +1.92% 37,655,550
24-06-12 6.77 -1.88% 33,885,060
24-06-11 6.9 -1.71% 57,175,740

Delayed Quote Hong Kong S.E., June 14, 2024 at 04:08 am

More quotes
CSPC Pharmaceutical Group Ltd. specializes in the development, manufacture and marketing of pharmaceutical products. Net sames by category of products break down as follows: - drugs (78.7%): innovative drugs (62.5% of sales) and common generic drugs (37.5%); - vitamin C (10.1%); - antibiotics (6.2%); - other (5%): including anhydrous and raw caffeine. Net sales are distributed geographically as follows: China (82.8%), Asia (7.2%), Europe (4.6%), the Americas (4.4%) and others (1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
6.82 HKD
Average target price
9.584 HKD
Spread / Average Target
+40.53%
Consensus